Replimune Group, Inc. REPL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

51/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Replimune Group, Inc. (REPL), dont 21 achats et 24 ventes. Le total des achats d'initiés s'élève à $8.05M et le total des ventes d'initiés à $2.07M.

Les initiés notables ayant une activité récente comprennent Sarchi Christopher, Astley-sparke Philip, Hill Emily Luisa. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — REPL

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-02	Sarchi Christopher	Chief Commercial Officer	Vente Informative	6,500	$8.01	$52.07K	151,588
2026-02-18	Astley-sparke Philip	Director	Don (Donné)	25,000	-	-	1,380,071
2025-12-19	Hill Emily Luisa	Chief Financial Officer	Attribution de RSU	60,000	-	-	194,368
2025-12-19	Patel Sushil	Chief Executive Officer	Attribution de RSU	200,000	-	-	533,576
2025-12-19	Xynos Konstantinos	Chief Medical Officer	Attribution de RSU	60,000	-	-	199,685
2025-12-19	Schwendenman Andrew	Chief Accounting Officer	Attribution de RSU	10,000	-	-	78,284
2025-12-19	Sarchi Christopher	Chief Commercial Officer	Attribution de RSU	35,000	-	-	158,088
2025-12-09	Dhingra Kapil	Director	Vente Informative	3,169	$10.40	$32.96K	-
2025-12-02	Patel Sushil	Chief Executive Officer	Vente Informative	10,000	$11.13	$111.3K	333,576
2025-11-17	Xynos Konstantinos	Chief Medical Officer	Vente Informative	7,248	$9.10	$65.96K	139,685
2025-11-17	Sarchi Christopher	Chief Commercial Officer	Vente Informative	5,208	$9.10	$47.39K	123,088
2025-08-15	Hill Emily Luisa	Chief Financial Officer	Vente Informative	9,154	$5.37	$49.16K	134,368
2025-05-20	Astley-sparke Philip	Director	Vente Informative	32,279	$8.06	$260.17K	1,405,071
2025-05-20	Hill Emily Luisa	Chief Financial Officer	Vente Informative	2,535	$8.05	$20.41K	143,522
2025-05-20	Patel Sushil	Chief Executive Officer	Vente Informative	25,105	$8.06	$202.35K	343,576
2025-05-20	Xynos Konstantinos	Chief Medical Officer	Vente Informative	7,952	$8.06	$64.09K	146,933
2025-05-20	Schwendenman Andrew	Chief Accounting Officer	Vente Informative	3,287	$8.05	$26.46K	68,284
2025-05-20	Sarchi Christopher	Chief Commercial Officer	Vente Informative	3,749	$8.05	$30.18K	128,296
2025-04-01	Slattery Joseph P	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Pucci Paolo	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Dhingra Kapil	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Balachandran Madhavan	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Weinand Dieter	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Hill Emily Luisa	Chief Financial Officer	Attribution de RSU	67,500	$8.40	$567K	67,500
2025-04-01	Oliger Christy J.	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Patel Sushil	Chief Executive Officer	Attribution de RSU	250,000	$8.40	$2.1M	250,000
2025-04-01	Xynos Konstantinos	Chief Medical Officer	Attribution de RSU	67,500	$8.40	$567K	67,500
2025-04-01	Schwendenman Andrew	Chief Accounting Officer	Attribution de RSU	50,000	$8.40	$420K	50,000
2025-04-01	Peeples-dyer Veleka	Director	Attribution de RSU	32,000	$8.40	$268.8K	32,000
2025-04-01	Sarchi Christopher	Chief Commercial Officer	Attribution de RSU	67,500	$8.40	$567K	67,500
2025-03-05	Baker Bros. Advisors Lp	10 Percent Owner	Inconnu	4,102,636	-	-	-
2025-03-05	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	64,000	$12.29	$786.56K	64,000
2025-03-05	Goller Michael	Officer	Inconnu	-	-	-	-
2024-12-16	Patel Sushil	Chief Executive Officer	Vente Informative	10,000	$12.42	$124.2K	202,014
2024-11-18	Xynos Konstantinos	Chief Medical Officer	Vente Informative	7,246	$10.78	$78.11K	109,885
2024-11-18	Sarchi Christopher	Chief Commercial Officer	Vente Informative	5,207	$10.78	$56.13K	87,045
2024-09-04	Balachandran Madhavan	Director	Inconnu	-	-	-	-
2024-09-04	Balachandran Madhavan	Director	Attribution de RSU	64,000	$10.44	$668.16K	64,000
2024-08-30	Astley-sparke Philip	Executive Chairman	Don (Donné)	50,000	-	-	1,437,350
2024-08-16	Hill Emily Luisa	Chief Financial Officer	Vente Informative	8,938	$10.18	$90.99K	101,057
2024-06-07	Xynos Konstantinos	Chief Medical Officer	Vente Informative	15,881	$7.50	$119.11K	117,131
2024-05-16	Astley-sparke Philip	Executive Chairman	Vente Informative	37,928	$6.47	$245.39K	1,487,350
2024-05-16	Coffin Robert	Director	Vente Informative	11,464	$6.47	$74.17K	1,821,872
2024-05-16	Love Colin	Chief Operating Officer	Vente Informative	17,615	$6.47	$113.97K	777,345
2024-05-16	Patel Sushil	Chief Executive Officer	Vente Informative	20,194	$6.47	$130.66K	212,014
2024-05-16	Xynos Konstantinos	Chief Medical Officer	Vente Informative	6,367	$6.47	$41.19K	133,012
2024-05-16	Schwendenman Andrew	Chief Accounting Officer	Vente Informative	2,298	$6.47	$14.87K	38,238
2024-05-16	Sarchi Christopher	Chief Commercial Officer	Vente Informative	2,218	$6.47	$14.35K	92,252
2024-04-01	Slattery Joseph P	Director	Attribution de RSU	32,000	$7.73	$247.36K	32,000
2024-04-01	Levitsky Hyam	Director	Attribution de RSU	32,000	$7.73	$247.36K	32,000

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration